ArticleACS applied bio materials2026
Biocompatible Microscale DNA Hydrogels with Programmable Swelling and Sequence-Specific Dissolution.
Article in ACS applied bio materials, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Stimulus-responsive DNA hydrogels with swelling capabilities are a promising class of materials for biomedical applications such as drug delivery and biosensing. However, translation of these systems to microscale applications requires fabrication methods that are both biocompatible and material-efficient, while enabling precise control over stimulus-induced swelling and its impact on molecular transport. Here, we present a biocompatible fabrication and characterization platform for microscale DNA-hydrogels (μSDs) with tunable isotropic swelling and dissolving properties. Our approach includes a biocompatible, material-efficient fabrication workflow that conserves valuable DNA reagents by minimizing dead volume and process loss. We then demonstrated modular control over isotropic swelling in μSDs, achieving up to a two-fold size increase through programmable DNA design parameters. We further established a quantitative reaction-diffusion workflow to estimate effective diffusivity and characterize swelling dependent transport of a DNA binding fluorescent probe in spherical μSDs. Finally, we demonstrate the dissolution of μSDs using a DNA strand and find that dissolution kinetics are governed by the rates of coupled strand-displacement reactions and diffusive transport. This platform enables programmable swelling and structural disassembly in μSDs. Swelling-induced network expansion further modulates transport of a DNA binding fluorescent probe within the μSD network, highlighting the potential of programmable structural remodeling for future biosensing, controlled release, and single-cell assay applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.